Systemic immunotherapy delays photoreceptor cell loss and prevents vascular pathology in Royal College of Surgeons rats

Molecular Vision

Volumn 18, Issue , 2012, Pages 2323-2337

  Adamus, Grazyna ^a   Wang, Shaomei ^a   Kyger, Madison ^a   Worley, Aneta ^a   Lu, Bin ^a   Burrows, Gregory G ^a,b  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; MONOCYTE CHEMOTACTIC PROTEIN 1; RETINOID BINDING PROTEIN; RTL 220; RTL101; T LYMPHOCYTE RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; AUTOIMMUNITY; CELL SURVIVAL; CONTROLLED STUDY; FEMALE; FLUORESCENCE ANGIOGRAPHY; HISTOPATHOLOGY; IMMUNOFLUORESCENCE TEST; IMMUNOTHERAPY; MALE; MICROGLIA; NONHUMAN; OPTOKINETIC STIMULATION; PHOTORECEPTOR CELL; PRIORITY JOURNAL; RAT; RETINA; RETINA DEGENERATION; RETINOPATHY; SYSTEMIC IMMUNOTHERAPY; VASCULAR DISEASE; VISION; VISUAL ACUITY;

AMINO ACID SEQUENCE; ANIMALS; AUTOANTIBODIES; AUTOIMMUNITY; BLOOD VESSELS; CHEMOKINE CCL2; DISEASE MODELS, ANIMAL; DRUG ADMINISTRATION SCHEDULE; FEMALE; IMMUNOTHERAPY; INJECTIONS, SUBCUTANEOUS; LIGANDS; MALE; MICROGLIA; MOLECULAR SEQUENCE DATA; PHOTORECEPTOR CELLS; RATS; RECOMBINANT FUSION PROTEINS; RETINAL DEGENERATION; RETINOL-BINDING PROTEINS; VISUAL ACUITY;

EID: 84866685759     PISSN: None     EISSN: 10900535     Source Type: Journal    
DOI: None     Document Type: Article

References (55)

1. Milam AH, Li ZY, Fariss RN. Histopathology of the human retina in retinitis pigmentosa. Prog Retin Eye Res 1998; 17:175-205. [PMID: 9695792]
2. Grunwald JE, Maguire AM, Dupont J. Retinal hemodynamics in retinitis pigmentosa. Am J Ophthalmol 1996; 122:502-8. [PMID: 8862046]
3. Gupta N, Brown KE, Milam AH. Activated microglia in human retinitis pigmentosa, late-onset retinal degeneration, and age-related macular degeneration. Exp Eye Res 2003; 76:463-71. [PMID: 12634111]
4. Marc RE, Jones BW, Watt CB, Strettoi E. Neural remodeling in retinal degeneration. Prog Retin Eye Res 2003; 22:607-55. [PMID: 12892644]
5. Penfold PL, Madigan MC, Gillies MC, Provis JM. Immunological and Aetiological Aspects of Macular Degeneration. Prog Retin Eye Res 2001; 20:385-414. [PMID: 11286898]
6. Donoso LA, Kim D, Frost A, Callahan A, Hageman G. The Role of Inflammation in the Pathogenesis of Age-related Macular Degeneration. Surv Ophthalmol 2006; 51:137-52. [PMID: 16500214]
7. Morohoshi K, Goodwin AM, Ohbayashi M, Ono SJ. Autoimmunity in retinal degeneration: Autoimmune retinopathy and age-related macular degeneration. J Autoimmun 2009; 33:247-54. [PMID: 19846275]
8. Adamus G. Autoantibody Targets and their Cancer Relationship in the Pathogenicity of Paraneoplastic Retinopathy. Autoimmun Rev 2009; 8:410-4. [PMID: 19168157]
9. Anderson DH, Radeke MJ, Gallo NB, Chapin EA, Johnson PT, Curletti CR, Hancox LS, Hu J, Ebright JN, Malek G, Hauser MA, Rickman CB, Bok D, Hageman GS, Johnson LV. The pivotal role of the complement system in aging and age-related macular degeneration: hypothesis re-visited. Prog Retin Eye Res 2010; 29:95-112. [PMID: 19961953]
10. Ross RJ, Zhou M, Shen D, Fariss RN, Ding X, Bojanowski CM, Tuo J, Chan CC. Immunological protein expression profile in Ccl2/Cx3cr1 deficient mice with lesions similar to age-related macular degeneration. Exp Eye Res 2008; 86:675-83. [PMID: 18308304]
11. Ezzat MK, Hann CR, Vuk-Pavlovic S, Pulido JS. Immune cells in the human choroid. Br J Ophthalmol 2008; 92:976-80. [PMID: 18577650]
12. Solomon A, Banin E, Anteby I, Benezra D. Retinitis pigmentosa, Coats disease and uveitis. Eur J Ophthalmol 1999; 9:202-5. [PMID: 10544975]
13. Ding X, Patel M, Chan CC. Molecular pathology of agerelated macular degeneration. Prog Retin Eye Res 2009; 28:1-18. [PMID: 19026761]
14. Villegas-Pérez MP, Lawrence JM, Vidal-Sanz M, Lavail MM, Lund RD. Ganglion cell loss in RCS rat retina: a result of compression of axons by contracting intraretinal vessels linked to the pigment epithelium. J Comp Neurol 1998; 392:58-77. [PMID: 9482233]
15. D'Cruz PM, Yasumura D, Weir J, Matthes MT, Abderrahim H, LaVail MM, Vollrath D. Mutation of the receptor tyrosine kinase gene Mertk in the retinal dystrophic RCS rat. Hum Mol Genet 2000; 9:645-51. [PMID: 10699188]
16. Adamus G, Burrows GG, Vandenbark AA, Offner H. Treatment of Autoimmune Anterior Uveitis with Recombinant TCR Ligands. Invest Ophthalmol Vis Sci 2006; 47:2555-61. [PMID: 16723470]
17. Adamus G, Karren L, Mooney J, Burrows G. A Promising Therapeutic Approach for Treatment of Posterior Uveitis: Recombinant T Cell Receptor Ligand Protects Lewis rats from Acute and Recurrent Experimental Autoimmune Uveitis. Ophthalmic Res 2010; 44:24-33. [PMID: 20145422]
18. Adamus G, Brown L, Andrew S, Meza-Romero R, Burrows GG, Vandenbark AA. Neuroprotective effects of recombinant t-cell receptor ligand in autoimmune optic neuritis in HLA-DR2 mice. Invest Ophthalmol Vis Sci 2012; 53:406-12. [PMID: 22167100]
19. Burrows GG, Chou YK, Wang C, Chang JW, Finn TP, Culbertson NE, Kim J, Bourdette DN, Lewinsohn DA, Lewinsohn DM, Ikeda M, Yoshioka T, Allen CN, Offner H, Vandenbark AA. Rudimentary TCR signaling triggers default IL-10 secretion by human Th1 cells. J Immunol 2001; 167:4386-95. [PMID: 11591763]
20. Prusky GT, Alam NM, Beekman S, Douglas RM. Rapid quantification of adult and developing mouse spatial vision using a virtual optomotor system. Invest Ophthalmol Vis Sci 2004; 45:4611-6. [PMID: 15557474]
21. Douglas RM, Alam NM, Silver BD, McGill TJ, Tschetter WW, Prusky GT. Independent visual threshold measurements in the two eyes of freely moving rats and mice using a virtual-reality optokinetic system. Vis Neurosci 2005; 22:677-84. [PMID: 16332278]
22. Wang S, Lu B, Girman S, Duan J, McFarland T, Zhang Q, Grompe M, Adamus G, Appukuttan B, Lund R. Noninvasive stem cell therapy in a rat model for retinal degeneration and vascular pathology. PLoS ONE 2010; 5:e9000. [PMID: 20140250]
23. McGill TJ, Lund RD, Douglas RM, Wang S, Lu B, Silver BD, Secretan MR, Arthur JN, Prusky GT. Syngeneic Schwann cell transplantation preserves vision in RCS rat without immunosuppression. Invest Ophthalmol Vis Sci 2007; 48:1906-12. [PMID: 17389527]
24. McGill TJ, Prusky GT, Douglas RM, Yasumura D, Matthes MT, Nune G, Donohue-Rolfe K, Yang H, Niculescu D, Hauswirth WW, Girman SV, Lund RD, Duncan JL, LaVail MM. Intraocular CNTF reduces vision in normal rats in a dose-dependent manner. Invest Ophthalmol Vis Sci 2007; 48:5756-66. [PMID: 18055829]
25. Lu B, Wang S, Girman S, McGill T, Ragaglia V, Lund R. Human adult bone marrow-derived somatic cells rescue vision in a rodent model of retinal degeneration. Exp Eye Res 2010; 91:449-55. [PMID: 20603115]
26. Link JM, Rich CM, Korat M, Burrows GG, Offner H, Vandenbark AA. Monomeric DR2/MOG-35-55 recombinant TCR ligand treats relapses of experimental encephalomyelitis in DR2 transgenic mice. Clin Immunol 2007; 123:95-104. [PMID: 17257899]
27. Burrows GG. Systemic Immunomodulation of Autoimmune Disease Using MHC-Derived Recombinant TCR Ligands. Curr Drug Targets Inflamm Allergy 2005; 4:185. [PMID: 15853741]
28. Karlstetter M, Ebert S, Langmann T. Microglia in the healthy and degenerating retina: Insights from novel mouse models. Immunobiology 2010; 215:685-91. [PMID: 20573418]
29. Joly S, Francke M, Ulbricht E, Beck S, Seeliger M, Hirrlinger P, Hirrlinger J, Lang KS, Zinkernagel M, Odermatt B, Samardzija M, Reichenbach A, Grimm C, Remé CE. Resident microglia and bone marrow immigrants remove dead photoreceptors in retinal lesions. Am J Pathol 2009; 174:2310-23. [PMID: 19435787]
30. Neuner-Jehle M, Berghe LV, Bonnel S, Uteza Y, Benmeziane F, Rouillot JS, Marchant D, Kobetz A, Dufier JL, Menasche M, Abitbol M. Ocular cell transfection with the human basic fibroblast growth factor gene delays photoreceptor cell degeneration in RCS rats. Hum Gene Ther 2000; 11:1875-90. [PMID: 10986560]
31. Vollrath D, Feng W, Duncan JL, Yasumura D, D'Cruz PM, Chappelow A, Matthes MT, Kay MA, LaVail MM. Correction of the retinal dystrophy phenotype of the RCS rat by viral gene transfer of Mertk. Proc Natl Acad Sci USA 2001; 98:12584-9. [PMID: 11592982]
32. Lawrence JM, Keegan DJ, Muir EM, Coffey PJ, Rogers JH, Wilby MJ, Fawcett JW, Lund RD. Transplantation of Schwann cell line clones secreting GDNF or BDNF into the retinas of dystrophic Royal College of Surgeons rats. Invest Ophthalmol Vis Sci 2004; 45:267-74. [PMID: 14691183]
33. Lu B, Malcuit C, Wang S, Girman S, Francis P, Lemieux L, Lanza R, Lund R. Long-term safety and function of RPE from human embryonic stem cells in preclinical models of macular degeneration. Stem Cells 2009; 27:2126-35. [PMID: 19521979]
34. Steinberg RH. Survival factors in retinal degenerations. Curr Opin Neurobiol 1994; 4:515-24. [PMID: 7812140]
35. Huang SP, Lin PK, Liu JH, Khor CN, Lee YJ. Intraocular gene transfer of ciliary neurotrophic factor rescues photoreceptor degeneration in RCS rats. J Biomed Sci 2004; 11:37-48. [PMID: 14730208]
36. Katai N, Yoshimura N. Apoptotic retinal neuronal death by ischemia-reperfusion is executed by two distinct caspase family proteases. Invest Ophthalmol Vis Sci 1999; 40:2697-705. [PMID: 10509668]
37. Porrello K, Yasumura D, LaVail MM. The interphotoreceptor matrix in RCS rats: Histochemical analysis and correlation with the rate of retinal degeneration. Exp Eye Res 1986; 43:413-29. [PMID: 3780883]
38. LaVail MM. Legacy of the RCS rat: impact of a seminal study on retinal cell biology and retinal degenerative diseases. In: Helga Kolb HR, Samuel Wu, H. Kolb, Samuel Miao-Sin Wu, John E, editors. Concepts and Challenges in Retinal Biology (Progress in Brain Research). Vol 131. Elsevier; 2001. p. 617-627
39. Ye F, Li Q, Ke Y, Lu Q, Han L, Kaplan HJ, Shao H, Lu Q. TAM Receptor Knockout Mice Are Susceptible to Retinal Autoimmune Induction. Invest Ophthalmol Vis Sci 2011; 52:4239-46. [PMID: 21467176]
40. Gal A, Li Y, Thompson DA, Weir J, Orth U, Jacobson SG, Apfelstedt-Sylla E, Vollrath D. Mutations in MERTK, the human orthologue of the RCS rat retinal dystrophy gene, cause retinitis pigmentosa. Nat Genet 2000; 26:270-1. [PMID: 11062461]
41. Holtkamp GM, Kijlstra A, Peek R, de Vos AF. Retinal pigment epithelium-immune system interactions: cytokine production and cytokine-induced changes. Prog Retin Eye Res 2001; 20:29-48. [PMID: 11070367]
42. Matsuda A, Tagawa Y, Yoshida K, Matsuda H, Nishihira J. Expression of macrophage migration inhibitory factor in rat retina and its immunohistochemical localization. J Neuroimmunol 1997; 77:85-90. [PMID: 9209272]
43. Burrows GG, Chang JW, Bachinger HP, Bourdette DN, Offner H, Vandenbark AA. Design, engineering and production of functional single-chain T cell receptor ligands. Protein Eng 1999; 12:771-8. [PMID: 10506287]
44. Chang JW, Mechling DE, Bachinger HP, Burrows GG. Design, engineering, and production of human recombinant t cell receptor ligands derived from human leukocyte antigen DR2. J Biol Chem 2001; 276:24170-6. [PMID: 11319230]
45. Huan J, Kaler LJ, Mooney JL, Subramanian S, Hopke C, Vandenbark AA, Rosloniec EF, Burrows GG, Offner H. MHC class II derived recombinant T cell receptor ligands protect DBA/1LacJ mice from collagen-induced arthritis. J Immunol 2008; 180:1249-57. [PMID: 18178865]
46. Sinha S, Miller L, Subramanian S, McCarty OJT, Proctor T, Meza-Romero R, Huan J, Burrows GG, Vandenbark AA, Offner H. Binding of recombinant T cell receptor ligands (RTL) to antigen presenting cells prevents upregulation of CD11b and inhibits T cell activation and transfer of experimental autoimmune encephalomyelitis. J Neuroimmunol 2010; 225:52-61. [PMID: 20546940]
47. Offner H, Sinha S, Wang C, Burrows GG, Vandenbark AA. Recombinant T cell receptor ligands: immunomodulatory, neuroprotective and neuroregenerative effects suggest application as therapy for multiple sclerosis. Rev Neurosci 2008; 19:327-39. [PMID: 19145988]
48. Offner H, Sinha S, Burrows GG, Ferro AJ, Vandenbark AA. RTL therapy for multiple sclerosis: A Phase I clinical study. J Neuroimmunol 2011; 231:7-14. [PMID: 20965577]
49. Sinha S, Subramanian S, Miller L, Proctor TM, Roberts C, Burrows GG, Vandenbark AA, Offner H. Cytokine Switch and Bystander Suppression of Autoimmune Responses to Multiple Antigens in Experimental Autoimmune Encephalomyelitis by a Single Recombinant T-Cell Receptor Ligand. J Neurosci 2009; 29:3816-23. [PMID: 19321778]
50. Roque RS, Imperial C, Caldwell R. Microglial cells invade the outer retina as photoreceptors degenerate in Royal College of Surgeons rats. Invest Ophthalmol Vis Sci 1996; 37:196-203. [PMID: 8550323]
51. Akaishi K, Ishiguro S-i, Durlu YK, Tamai M. Quantitative Analysis of Major Histocompatibility Complex Class IIPositive Cells in Posterior Segment of Royal College of Surgeons Rat Eyes. Jpn J Ophthalmol 1998; 42:357-62. [PMID: 9822962]
52. Moore S, Thanos S. The concept of microglia in relation to central nervous system disease and regeneration. Prog Neurobiol 1996; 48:441-60. [PMID: 8804116]
53. Sinha S, Subramanian S, Proctor TM, Kaler LJ, Grafe M, Dahan R, Huan J, Vandenbark AA, Burrows GG, Offner H. A promising therapeutic approach for multiple sclerosis: recombinant T-cell receptor ligands modulate experimental autoimmune encephalomyelitis by reducing interleukin-17 production and inhibiting migration of encephalitogenic cells into the CNS. J Neurosci 2007; 27:12531-9. [PMID: 18003831]
54. Itakura A, Aslan JE, Sinha S, White-Adams TC, Patel IA, Meza-Romero R, Vandenbark AA, Burrows GG, Offner H, McCarty OJ. Characterization of human platelet binding of recombinant T cell receptor ligand. J Neuroinflammation 2010; 7:75. [PMID: 21059245]
55. Wang S, Villegas-Perez MP, Holmes T, Lawrence JM, Vidal-Sanz M, Hurtado-Montalban N, Lund RD. Evolving neurovascular relationships in the RCS rat with age. Curr Eye Res 2003; 27:183-96. [PMID: 14562184]